|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2010-3-22
|
|
pubmed:abstractText |
Posttransplant diabetes mellitus (PTDM) is considered to be a serious complication of kidney transplantation that may reduce patient and graft survival. The immunosuppressant tacrolimus (TAC) increases the risk of developing PTDM.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1873-2623
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright (c) 2010 Elsevier Inc. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
42
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
475-8
|
|
pubmed:meshHeading |
pubmed-meshheading:20304169-Adolescent,
pubmed-meshheading:20304169-Adult,
pubmed-meshheading:20304169-Body Mass Index,
pubmed-meshheading:20304169-Cyclosporine,
pubmed-meshheading:20304169-Diabetes Mellitus,
pubmed-meshheading:20304169-Female,
pubmed-meshheading:20304169-Graft Rejection,
pubmed-meshheading:20304169-Humans,
pubmed-meshheading:20304169-Immunosuppressive Agents,
pubmed-meshheading:20304169-Incidence,
pubmed-meshheading:20304169-Kidney Transplantation,
pubmed-meshheading:20304169-Living Donors,
pubmed-meshheading:20304169-Male,
pubmed-meshheading:20304169-Postoperative Complications,
pubmed-meshheading:20304169-Retrospective Studies,
pubmed-meshheading:20304169-Risk Factors,
pubmed-meshheading:20304169-Sirolimus,
pubmed-meshheading:20304169-Tacrolimus,
pubmed-meshheading:20304169-Tissue Donors
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Use of tacrolimus and the development of posttransplant diabetes mellitus: a Brazilian single-center, observational study.
|
|
pubmed:affiliation |
Irmandade da Santa Casa de Misericórdia de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. diegognatta@yahoo.com.br
|
|
pubmed:publicationType |
Journal Article
|
